Vertex Pharmaceuticals Price to Earning

VRTX -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Vertex Pharmaceuticals price-to-earning fundamental analysis lookup allows you to check this and other indicators for Vertex Pharmaceuticals Incorpor or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Vertex Pharmaceuticals Price to Earning Analysis

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
 2015 2016 2017 2018 2019 (projected)
Receivables 177,639,000  201,083,000  310,250,000  414,870,000  293,404,655 
Inventories 57,207,000  77,604,000  111,830,000  124,360,000  94,867,895 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
More About Price to Earning | All Equity Analysis
Vertex Pharmaceuticals Price to Earning  =
26.09 
Vertex Pharmaceuticals ValuationFundamentalsBuy or Sell

Vertex Pharmaceuticals Price to Earning Over Time Pattern

 Vertex Pharmaceuticals Price to Earnings Ratio 
      Timeline 

About Price to Earning

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition

Vertex Pharmaceuticals Price to Earning Assessment

Accumulated Retained Earnings Deficit
Based on latest financial disclosure the price to earning indicator of Vertex Pharmaceuticals Incorpor is roughly 26.09 times. This indicator is about the same for the Healthcare average (which is currently at 25.84) sector, and 429.21% higher than that of Biotechnology industry, The Price to Earning for all stocks is 9.16% higher than the company.

Did you try this?

Run Cryptocurrency Correlation Now

   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
All  Next Launch Module

Vertex Pharmaceuticals current financial ratios



 
Search macroaxis.com